Tumor Biorepository

In 2016, the Pediatric Oncology Program at C.S. Mott Children’s Hospital established a biorepository to store samples from patients seen in our clinic.

The biorepository was designed to be a robust resource for physicians and other researchers who are devoted to searching for new and improved treatments for childhood cancer.

Tumor biorepository graphi

Since its establishment, the U-M pediatric oncology biorepository has contributed to a range of projects, including:

  • Developing new immunotherapy agents for pediatric AML patients
  • Detecting circulating tumor cells in cerebrospinal fluid as a technique for monitoring disease in pediatric patients with CNS tumors
  • Studying Ras-activating mutations in pediatric oncology patients as a method for developing therapeutic targets

For more information about pediatric oncology research at C.S. Mott Children’s Hospital, contact our clinical research coordinator or at 734-232-4046.